How we are making a difference in the fight against COVID-19

“Typically with trials, we have to bring the patients to us. This is the first of its kind, where Care Access Research is actually bringing the trial to them.”

News Coverage

Our Work. Our Teams. In Action.

AstraZeneca joins with Care Access Research on COVID-19 antibody trial

2/23/2021 - Outsourcing Pharma

Care Access Research Collaborates with AstraZeneca on Phase III Clinical Trial for COVID-19 Long-Acting Antibody Combination

01/26/2021 - Care Access

Lilly, Care Access Take COVID Trial Directly To Patients

12/10/2020 - Clinical Leader

Lilly, NIAID & Care Access Research Transform How Studies Done to Reach Nursing Homes During COVID-19 Pandemic

10/12/2020 - Trial Site News

How Lilly’s COVID-19 Nursing Home Trial Could Change the Future of Research in Long-Term Care

10/11/2020 - Skilled Nursing News

A top US drugmaker is teaming up with the Gates Foundation to get a promising new coronavirus treatment to low-income countries before April 2021

10/08/2020 - Business Insider

Eli Lilly Asks FDA to Authorize Covid-19 Antibody Drug

10/07/2020 - Wall Street Journal

Care Access Research Partners on Mobile Trial for COVID-19 Treatment

10/01/2020 - Applied Clinical Trials

An Experimental Drug Protects Covid-19 Patients, Eli Lilly Claims

09/16/2020 - New York Times

An ‘Unprecedented’ Effort to Stop the Coronavirus in Nursing Homes

08/20/2020 - New York Times

Care Access Research Validation Study of COVID-19 At-Home Saliva Test by Phosphorus is Granted EUA by FDA

7/02/2020 - Care Access Research

Care Access Research Launches COVID-19 Clinical Trials Alliance to Accelerate Vaccine and Drug Development

4/09/2020 - Care Access Research

You can be a part of the solution.
Help us save lives and make history.

Explore All Opportunities

We are the founding member of the COVID-19 Clinical Trials Alliance, whose goal is to foresee and remove the logistical bottlenecks inherent to the clinical trial industry, so that we can save lives and end the pandemic.